Yahoo Web Search

Search results

1. • NRx Pharmaceuticals climbs on positive results from its bipolar depression treatment trial

     Seeking Alpha· 17 hours ago

     NRx Pharmaceuticals announces statistically significant safety advantage of NRX-101 in suicidal bipolar depression trial.

2. • 

     I had a severe reaction to medication I took for depression — it burned me from the inside out

     New York Post· 10 hours ago

     Gilmour isn’t the only New Zealander to have developed the painful condition after taking a mood...

3. • ...) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for...

     KTLA-TV Los Angeles· 7 days ago

     NRX-101 is first oral antidepressant to show 33% advantage in sustained remission in suicidality (not statistically significant at this sample size) and 75% advantage in relief from Akathisia ...

4. • Bipolar Depression Pill Fails; Magnetic Seizure vs ECT; Lifetime Loneliness Curve

     MedPage Today· 6 days ago

     Compared with lurasidone (Latuda), the investigational oral antidepressant NRX-101 did not significantly reduce suicidality in people with bipolar depression</ ...

5. • 

     Psilocybin from Magic Mushrooms May Help Treat Depression

     Healthline· 4 days ago

     A study has found that psilocybin appears to have antidepressant properties. Experts say it...

6. • 

     Selena Gomez recalls how some people didn't want her to reveal her bipolar diagnosis

     TODAY via Yahoo News· 4 days ago

     Two years later, Gomez later entered a treatment facility in 2018 to help manage her anxiety and ...

7. • 

     Is marijuana legal in Texas? What you need to know about the state’s pot laws.

     FOX 4 News Dallas - Fort Worth· 6 days ago

     Legislation meant to expand the use of legal marijuana moves a step closer to law in Texas this...

8. • 

     Texas ban on Delta-8 could be deadly, CBD shop owner says

     San Antonio Express-News· 2 days ago

     Texas Lt. Gov. Dan Patrick’s 2025 legislative agenda calls for Texas officials to investigate the...

9. • Neurocrine Biosciences Announces U.S. FDA Approval of INGREZZA® SPRINKLE (valbenazine) Capsules

     Hi-Desert Star· 6 days ago

     Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the U.S. Food and Drug Administration has approved INGREZZA® SPRINKLE (valbenazine) capsules, a new oral granules formulation of INGREZZA ...

10. • May is Mental Health Awareness Month. Experts and Patients Available for Interviews on Trending...

      Newswise· 4 days ago

      More than one in five adults in the U.S. lives with mental illness, and a quarter of U.S. adults have acute mental illness, which includes major depression and bipolar ...